Provided by Tiger Trade Technology Pte. Ltd.

iShares Biotechnology ETF

213.56
+2.731.29%
Post-market: 214.490.9300+0.44%19:57 EDT
Volume:2.68M
Turnover:573.86M
Market Cap:10.65B
PE:33.83
High:215.61
Open:211.55
Low:211.06
Close:210.83
52wk High:217.06
52wk Low:136.89
Shares:49.85M
Float Shares:49.85M
Volume Ratio:1.59
T/O Rate:5.38%
Dividend:0.41
Dividend Rate:0.19%
EPS(TTM):6.31
EPS(LYR):-1.4940
ROE:24.54%
ROA:0.10%
PB:1.31
PE(LYR):-142.95

Loading ...

Exchange-Traded Funds Mixed, US Equities Fall After Midday

MT Newswires Live
·
Aug 12

Amgen’s AMG 355 Trial Completion: What This Early Cancer Study Means for AMGN Investors

TIPRANKS
·
Aug 12

Global Drugmakers Invest Billions to Boost US Presence

Reuters
·
Aug 11

Tango Falls After Wider-than-Expected Quarterly Loss

Reuters
·
Aug 11

Jefferies Remains a Buy on Vertex Pharmaceuticals (VRTX)

TIPRANKS
·
Aug 11

Neurogene Advances Rett Gene Therapy Program and Extends Cash Runway to 2029

TIPRANKS
·
Aug 11

Analysts Conflicted on These Healthcare Names: GE Healthcare Technologies Inc (GEHC), Vertex Pharmaceuticals (VRTX) and Agios Pharma (AGIO)

TIPRANKS
·
Aug 11

Vertex Pharmaceuticals Incorporated : Bofa Global Research Adds Stock to Its US 1 List

THOMSON REUTERS
·
Aug 11

Infinimmune Raises $75 Million Series a Financing to Advance Pipeline of Human-Derived Antibodies for Atopic Dermatitis and Inflammatory Disease

Reuters
·
Aug 11

BIO-key International Enters into $2.5 Million Warrant Inducement Transaction

GlobeNewswire
·
Aug 11

Xinjiang Bai Hua Clarifies No Role in Innovative Drug Development

Stock News
·
Aug 11

Infinimmune: $75 Mln Series a Financing Co-Led by Regeneron Ventures and Playground Global

THOMSON REUTERS
·
Aug 11

Vertex Pharmaceuticals added to ‘US 1 List’ at BofA

TIPRANKS
·
Aug 11

AI Reshapes Drug Discovery Foundation, Domestic Industry Chain Expected to Benefit

Stock News
·
Aug 11

Vertex Pharmaceuticals Incorporated : Jefferies Raises Target Price to $633 from $610

THOMSON REUTERS
·
Aug 11

Breaking News

MT Newswires Live
·
Aug 11

Lakefront Biotherapeutics Boosts Immunology Push With Ouro Deal and Strong Cash Outlook

TIPRANKS
·
Aug 11

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Aug 11

Lakefront Biotherapeutics H1 FY26 Net Sales Drop 87% to EUR 18.6 Million; Operating Loss Narrows 54% to EUR 107.2 Million

Reuters
·
Aug 11

Nurix Therapeutics' STAT6 Degrader Likely to Receive Increased Recognition, RBC Says

MT Newswires Live
·
Aug 11